[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100610456":3},{"organization":4,"armGroups":7,"interventions":20,"overallOfficials":28,"centralContacts":32,"locations":38,"responsibleParty":202,"collaborators":25,"id":204,"slug":25,"hasResults":205,"nctId":206,"briefTitle":207,"officialTitle":208,"acronym":25,"eligibilityCriteria":209,"healthyVolunteers":205,"sex":210,"minAge":211,"maxAge":212,"enrollmentInfo":213,"targetDuration":25,"studyType":216,"phases":217,"briefSummary":219,"conditions":220,"keywords":222,"overallStatus":41,"whyStopped":25,"lastUpdateSubmitDate":223,"lastUpdatePostDateStruct":224,"startDateStruct":227,"completionDateStruct":229,"leadSponsor":231,"locationsCount":232},{"fullName":5,"class":6},"Neurocrine Biosciences","INDUSTRY",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"NBI-1117568","EXPERIMENTAL","All participants will receive NBI-1117568 during the Open-label Stabilization Period, then will be randomized to receive NBI-1117568 during the Double-blind Treatment Period.",[13],"Drug: NBI-1117568",{"label":15,"type":16,"description":17,"interventionNames":18},"Placebo","PLACEBO_COMPARATOR","All participants will receive NBI-1117568 during the Open-label Stabilization Period, then will be randomized to receive placebo matching NBI-1117568 during the Double-blind Treatment Period.",[13,19],"Drug: Placebo",[21,26],{"type":22,"name":9,"description":23,"armGroupLabels":24,"otherNames":25},"DRUG","Oral capsules",[9,15],null,{"type":22,"name":15,"description":23,"armGroupLabels":27,"otherNames":25},[15],[29],{"name":30,"affiliation":5,"role":31},"Clinical Development Lead","STUDY_DIRECTOR",[33],{"name":34,"role":35,"phone":36,"phoneExt":25,"email":37},"Neurocrine Medical Information Call Center","CONTACT","1-877-641-3461","medinfo@neurocrine.com",[39,52,60,68,76,84,92,101,109,117,122,130,137,146,155,164,173,180,185,193],{"facility":40,"status":41,"city":42,"state":43,"zip":44,"country":45,"cosmosGeoPoint":46,"geoPoint":51,"contacts":25},"Neurocrine Clinical Site","RECRUITING","Garden Grove","California","92845","United States",{"type":47,"coordinates":48},"Point",[49,50],-117.94145,33.77391,{"lat":50,"lon":49},{"facility":40,"status":41,"city":53,"state":43,"zip":54,"country":45,"cosmosGeoPoint":55,"geoPoint":59,"contacts":25},"La Habra","90631",{"type":47,"coordinates":56},[57,58],-117.94617,33.93196,{"lat":58,"lon":57},{"facility":40,"status":41,"city":61,"state":43,"zip":62,"country":45,"cosmosGeoPoint":63,"geoPoint":67,"contacts":25},"Lemon Grove","91945",{"type":47,"coordinates":64},[65,66],-117.03142,32.74255,{"lat":66,"lon":65},{"facility":40,"status":41,"city":69,"state":43,"zip":70,"country":45,"cosmosGeoPoint":71,"geoPoint":75,"contacts":25},"Oceanside","92056",{"type":47,"coordinates":72},[73,74],-117.37948,33.19587,{"lat":74,"lon":73},{"facility":40,"status":41,"city":77,"state":43,"zip":78,"country":45,"cosmosGeoPoint":79,"geoPoint":83,"contacts":25},"Torrance","90504",{"type":47,"coordinates":80},[81,82],-118.34063,33.83585,{"lat":82,"lon":81},{"facility":40,"status":41,"city":85,"state":43,"zip":86,"country":45,"cosmosGeoPoint":87,"geoPoint":91,"contacts":25},"West Hills","91307",{"type":47,"coordinates":88},[89,90],-118.64398,34.19731,{"lat":90,"lon":89},{"facility":40,"status":41,"city":93,"state":94,"zip":95,"country":45,"cosmosGeoPoint":96,"geoPoint":100,"contacts":25},"Hollywood","Florida","33024",{"type":47,"coordinates":97},[98,99],-80.14949,26.0112,{"lat":99,"lon":98},{"facility":40,"status":41,"city":102,"state":94,"zip":103,"country":45,"cosmosGeoPoint":104,"geoPoint":108,"contacts":25},"Maitland","32751",{"type":47,"coordinates":105},[106,107],-81.36312,28.62778,{"lat":107,"lon":106},{"facility":40,"status":41,"city":110,"state":94,"zip":111,"country":45,"cosmosGeoPoint":112,"geoPoint":116,"contacts":25},"Miami","33122",{"type":47,"coordinates":113},[114,115],-80.19366,25.77427,{"lat":115,"lon":114},{"facility":40,"status":41,"city":110,"state":94,"zip":118,"country":45,"cosmosGeoPoint":119,"geoPoint":121,"contacts":25},"33155",{"type":47,"coordinates":120},[114,115],{"lat":115,"lon":114},{"facility":40,"status":41,"city":123,"state":94,"zip":124,"country":45,"cosmosGeoPoint":125,"geoPoint":129,"contacts":25},"Tampa","33629",{"type":47,"coordinates":126},[127,128],-82.45843,27.94752,{"lat":128,"lon":127},{"facility":40,"status":41,"city":131,"state":94,"zip":95,"country":45,"cosmosGeoPoint":132,"geoPoint":136,"contacts":25},"West Palm Beach",{"type":47,"coordinates":133},[134,135],-80.05337,26.71534,{"lat":135,"lon":134},{"facility":40,"status":41,"city":138,"state":139,"zip":140,"country":45,"cosmosGeoPoint":141,"geoPoint":145,"contacts":25},"Atlanta","Georgia","30318",{"type":47,"coordinates":142},[143,144],-84.38798,33.749,{"lat":144,"lon":143},{"facility":40,"status":41,"city":147,"state":148,"zip":149,"country":45,"cosmosGeoPoint":150,"geoPoint":154,"contacts":25},"Boston","Massachusetts","02116",{"type":47,"coordinates":151},[152,153],-71.05977,42.35843,{"lat":153,"lon":152},{"facility":40,"status":41,"city":156,"state":157,"zip":158,"country":45,"cosmosGeoPoint":159,"geoPoint":163,"contacts":25},"Flowood","Mississippi","39232",{"type":47,"coordinates":160},[161,162],-90.13898,32.30959,{"lat":162,"lon":161},{"facility":40,"status":41,"city":165,"state":166,"zip":167,"country":45,"cosmosGeoPoint":168,"geoPoint":172,"contacts":25},"Cedarhurst","New York","11516",{"type":47,"coordinates":169},[170,171],-73.7243,40.62288,{"lat":171,"lon":170},{"facility":40,"status":41,"city":166,"state":166,"zip":174,"country":45,"cosmosGeoPoint":175,"geoPoint":179,"contacts":25},"10029",{"type":47,"coordinates":176},[177,178],-74.00597,40.71427,{"lat":178,"lon":177},{"facility":40,"status":41,"city":166,"state":166,"zip":181,"country":45,"cosmosGeoPoint":182,"geoPoint":184,"contacts":25},"10036",{"type":47,"coordinates":183},[177,178],{"lat":178,"lon":177},{"facility":40,"status":41,"city":186,"state":166,"zip":187,"country":45,"cosmosGeoPoint":188,"geoPoint":192,"contacts":25},"The Bronx","10461",{"type":47,"coordinates":189},[190,191],-73.86641,40.84985,{"lat":191,"lon":190},{"facility":40,"status":41,"city":194,"state":195,"zip":196,"country":45,"cosmosGeoPoint":197,"geoPoint":201,"contacts":25},"Bellevue","Washington","98007",{"type":47,"coordinates":198},[199,200],-122.20068,47.61038,{"lat":200,"lon":199},{"type":203,"investigatorFullName":25,"investigatorTitle":25,"investigatorAffiliation":25,"oldNameTitle":25,"oldOrganization":25},"SPONSOR","100610456",false,"NCT07227818","Efficacy of NBI-1117568 in Preventing Relapse in Adults With Schizophrenia","A Phase 3, Multicenter, Double-Blind, Placebo-Controlled, Randomized Withdrawal Study to Assess the Efficacy of NBI-1117568 in Preventing Relapse of the Symptoms of Schizophrenia and to Assess the Safety and Tolerability of NBI-1117568 in Adults With Schizophrenia","Key Inclusion Criteria:\n\n* Participant has a primary diagnosis of schizophrenia established by a comprehensive psychiatric evaluation based on the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition, Text Revision (DSM-5-TR) criteria.\n* Participant had the initial diagnosis of schizophrenia ≥1 year before screening.\n* Participant has had a positive response to ≥1 antipsychotic therapy (other than clozapine) at a therapeutic dose.\n\nKey Exclusion Criteria:\n\n* Participant has an unstable or poorly controlled medical condition or chronic disease (including history of neurological \\[including dementing illness, myasthenia gravis\\], hepatic, renal, cardiovascular, gastrointestinal, pulmonary, autoimmune, or endocrine disease that may affect study participation or results) or malignancy within 30 days before Day 1.\n* Participant has any laboratory abnormalities suggestive of clinically significant, poorly managed, or unmanaged undiagnosed disease.\n* Participant has a history of clozapine treatment for treatment-resistant psychosis.\n* Participant has a history of a stay in a psychiatric inpatient facility for ≥30 consecutive days (other than for purely social reasons or due to participation in a different clinical trial) during the 90 days before screening.\n* Participant has initiated or increased intensity of nonpharmacological psychosocial therapeutic treatment within 3 weeks before screening or is expected to change throughout the length of the study.\n\nNote: Other protocol-defined Inclusion and Exclusion criteria may apply.","ALL","18 Years","65 Years",{"count":214,"type":215},560,"ESTIMATED","INTERVENTIONAL",[218],"PHASE3","The main objective of the study is to evaluate NBI-1117568 compared with placebo in delaying relapse of symptoms of schizophrenia in adults who have a stable response after open-label treatment with NBI-1117568.",[221],"Schizophrenia",[221,9],"2026-06-04",{"date":225,"type":226},"2026-06-05","ACTUAL",{"date":228,"type":226},"2025-12-16",{"date":230,"type":215},"2029-07",{"name":5,"class":6},20]